Local News

• Forbes Medi-Tech announces corporate restructuring  Forbes Medi-Tech announced a plan to focus exclusively on its revenue-generating nutraceutical business, which includes functional foods and dietary supplements, and cease all in-house drug development activities. The restructuring plan involves staff reductions across various departments.
  Forbes Medi-Tech Inc. May 15, 2008  
• Wyeth's major depressive disorder treatment Pristiq now available in U.S. pharmacies  Wyeth Pharmaceuticals announced that PRISTIQ(TM), a new serotonin-norepinephrine reuptake inhibitor approved to treat adult patients with major depressive disorder, is now available in U.S. retail pharmacies nationwide. The recommended dose of PRISTIQ is 50 milligrams (mg) once daily.
  Wyeth May 15, 2008  
• Chemokine Therapeutics announces first quarter 2008 financial and operating results  Chemokine Therapeutics announced the financial and operating results of the first quarter ended March 31, 2008. The Company incurred a net loss of $751,931 ($0.02 per share) for the three months ended March 31, 2008 compared to $1,611,937 ($0.04 per share) for the three months ended March 31, 2007.
  Chemokine Therapeutics Corp. May 15, 2008  
• FDA approves AstraZeneca’s Seroquel for maintenance treatment in bipolar disorder  AstraZeneca announced that the U.S. Food and Drug Administration has approved SEROQUEL(R) (quetiapine fumarate) for the maintenance treatment of patients with bipolar I disorder, as adjunct to lithium or divalproex.
  AstraZeneca May 14, 2008  
• DuPont and Genencor create world-leading cellulosic ethanol company  DuPont and Genencor announced an agreement to form DuPont Danisco Cellulosic Ethanol, a 50/50 global joint venture to develop and commercialize the leading, low-cost technology solution for the production of cellulosic ethanol to address a $75 billion global market opportunity.
  Genencor May 14, 2008  
• F.D.A. chief writes Congress for money  After being pummeled for weeks on Capitol Hill over the president's budget, Food and Drug Commissioner Andrew C. von Eschenbach has written Congress that the agency needs an immediate infusion of $275 million to ensure that imported foods, drugs and medical devices are safe.
  The New York Times May 14, 2008  Gardiner Harris
• Maker of Cold-fX(R) opens new headquarters and research facility in Edmonton Research Park  CV Technologies will officially open its new $11 million headquarters and research facilities in the Edmonton Research Park allowing it to ramp up product pipeline goals as part of a five-year business plan.
  CV Technologies Inc. May 14, 2008  
• Lilly employees from nearly 50 nations participate in first-ever Global Day of Service  Thousands of Eli Lilly and Company employees in nearly 50 nations are rolling up their sleeves to help address local community needs in celebration of Lilly's first-ever Global Day of Service, possibly the largest corporate volunteer initiative to ever take place on one day.
  Eli Lilly and Company May 14, 2008  
• BioLife Solutions announces FDA Master File Acceptance for CryoStor™  BioLife Solutions, a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced that its Master File for CryoStor cryopreservation media has been accepted by the US Food and Drug Administration (FDA).
  BioLife Solutions Inc. May 14, 2008  
• Oncothyreon to receive milestone payment  Oncothyreon announced that it has completed the transfer of certain assays and manufacturing technology related to Stimuvax(R) (BLP25 liposome vaccine) to Merck KGaA of Darmstadt, Germany, triggering a payment to Oncothyreon of $3 million.
  Oncothyreon Inc. May 14, 2008  

   (next 10 articles)